Publikationen, an denen er mitarbeitet Alfredo Minguela Puras (18)

2024

  1. HLA-C*07 is associated with symptomatic HIV-1-associated neurocognitive disorders (HAND) and immune dysregulation

    Infectious Diseases

2021

  1. Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated with the Severity of Coronavirus Disease 2019

    Journal of Infectious Diseases, Vol. 224, Núm. 2, pp. 229-240

  2. CD8+ T lymphocytes are sensitive to NKG2A/HLA-E licensing interaction: role in the survival of cancer patients

    OncoImmunology, Vol. 10, Núm. 1

  3. Expression of nk cell receptor ligands on leukemic cells is associated with the outcome of childhood acute leukemia

    Cancers, Vol. 13, Núm. 10

  4. Immunological Risk Stratification of Bladder Cancer Based on Peripheral Blood Natural Killer Cell Biomarkers

    European urology oncology, Vol. 4, Núm. 2, pp. 246-255

  5. Predictive value of 1q21 gain in multiple myeloma is strongly dependent on concurrent cytogenetic abnormalities and first-line treatment

    AMERICAN JOURNAL OF CANCER RESEARCH, Vol. 11, Núm. 9, pp. 4438-4456

  6. Proliferation to apoptosis tumor cell ratio as a biomarker to improve clinical management of pre-malignant and symptomatic plasma cell neoplasms

    International Journal of Molecular Sciences, Vol. 22, Núm. 8

2020

  1. Kir+ cd8+ t lymphocytes in cancer immunosurveillance and patient survival: Gene expression profiling

    Cancers, Vol. 12, Núm. 10, pp. 1-20

2019

  1. Activating KIRs on educated NK cells support downregulation of CD226 and inefficient tumor immunosurveillance

    Cancer Immunology Research, Vol. 7, Núm. 8, pp. 1307-1317

  2. NKG2D polymorphism in melanoma patients from Southeastern Spain

    Cancers, Vol. 11, Núm. 4

2018

  1. NK cell education in tumor immune surveillance: DNAM-1/KIR receptor ratios as predictive biomarkers for solid tumor outcome

    Cancer Immunology Research, Vol. 6, Núm. 12, pp. 1537-1547

2016

  1. Circulating aberrant plasma cells allow risk stratification of patients with myeloma

    American Journal of Hematology

  2. Epidemiology, Evolution, and Long-Term Survival of Alcoholic Cirrhosis Patients Submitted to Liver Transplantation in Southeastern Spain

    Alcoholism: Clinical and Experimental Research, Vol. 40, Núm. 4, pp. 794-805

  3. Overexpression of KIR inhibitory ligands (HLA-I) determines that immunosurveillance of myeloma depends on diverse and strong NK cell licensing

    OncoImmunology, Vol. 5, Núm. 4

2015

  1. MHC class i chain-related gene a diversity in patients with cutaneous malignant melanoma from southeastern Spain

    Disease Markers, Vol. 2015

2013

  1. KIR gene mismatching and KIR/C ligands in liver transplantation: Consequences for short-term liver allograft injury

    Transplantation, Vol. 95, Núm. 8, pp. 1037-1044

  2. Post-transplant increase in soluble human leukocyte antigen-G associated with non-severe cardiac allograft vasculopathy

    Human Immunology, Vol. 74, Núm. 3, pp. 318-324

2011

  1. Divergences in KIR2D+ natural killer and KIR2D+CD8+ T-cell reconstitution following liver transplantation

    Human Immunology, Vol. 72, Núm. 3, pp. 229-237